Open AccessINTERNATIONAL MULTICENTER EXPERIENCE IN THE TREATMENT OF INVASIVE ASPERGILLOSIS IN IMMUNOCOMPROMISED CANCER PATIENTS
Author(s) -
Ray Hachem,
Marjorie Vieira Batista,
Souha S. Kanj,
Saeed El Zein,
Sara Haddad,
Ying Jiang,
Nobuyoshi Mori,
Rocha Vanderson,
AnneMarie Chaftari,
Issam Raad
Publication year - 2019
Publication title -
mediterranean journal of hematology and infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.682
H-Index - 31
ISSN - 2035-3006
DOI - 10.4084/mjhid.2019.003
Subject(s) - medicine , voriconazole , regimen , aspergillosis , amphotericin b , immunology , antifungal , dermatology
Based on international experience in immunocompromised cancer patients with IA, primary therapy with voriconazole-containing regimen is associated with improved response and survival compared with non-voriconazole amphotericin B based regimen.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom